An exciting Project-ALS funded study on the involvement of the gene TDP-43 in ALS-frontotemporal dementia. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic efforts. Read here
An exciting Project-ALS funded study on the involvement of the gene TDP-43 in ALS-frontotemporal dementia. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic efforts. Read here
Dear Friends, BREAKING NEWS: The all-new drug developed by the Project ALS Therapeutics Core for the treatment of ALS, is now moving into Phase 1
A LOOK BACK… LEARN MORE DEEPER DIVE INTO THE EARLY YEARS Project ALS Research LIVE: 25 Years of Progress The Beginning Years Hosted by Erin
NEW MAILING ADDRESS
2585 Broadway, Suite 202
New York, NY 10025
Phone: (212) 420-7382
Email: [email protected]
